14-1-3291 U.S. Producer Questionnaire

OMB No. 3117-0016/USITC No. 14-1-3291; Expiration Date: 6/30/2017
(No response is required if currently valid OMB control number is not displayed)

U.S. PRODUCERS’ QUESTIONNAIRE
CALCIUM HYPOCHLORITE FROM CHINA

This questionnaire must be received by the Commission by no later than OCTOBER 2, 2014
See the Instruction Booklet for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its countervailing duty and antidumping duty investigations concerning calcium hypochlorite (“calhypo”)
from China (Inv. Nos. 701-TA-510 and 731-TA-1245 (Final)). The information requested in the questionnaire is
requested under the authority of the Tariff Act of 1930, title VII. This report is mandatory and failure to reply as directed
can result in a subpoena or other order to compel the submission of records or information in your firm’s possession (19
U.S.C. § 1333(a)).

Name of firm
Address
City

State

Zip Code

World Wide Web address
Has your firm produced calhypo (as defined in the instruction booklet) at any time since January 1, 2011?

NO

(Sign the certification below and promptly return only this page of the questionnaire to the Commission)

YES

(Read the instruction booklet carefully, complete all parts of the questionnaire, and return the entire
questionnaire to the Commission so as to be received by the date indicated above)

Return questionnaire via the U.S. International Trade Commission Drop Box by clicking
on the following link: https://dropbox.usitc.gov/oinv/. (use the following PIN: HYPO)
CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my knowledge
and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this proceeding in any other import-injury proceedings conducted by
the Commission on the same or similar merchandise.
I acknowledge that information submitted in this questionnaire response and throughout this proceeding may be used by the
Commission, its employees, and contract personnel who are acting in the capacity of Commission employees, for developing or
maintaining the records of this proceeding or related proceedings for which this information is submitted, or in internal audits and
proceedings relating to the programs and operations of the Commission pursuant to 5 U.S.C. Appendix 3. I understand that all
contract personnel will sign non-disclosure agreements.

Name of Authorized Official

Title of Authorized Official

Date

Phone:
Signature

Email address
Fax:

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 2

PART I.—GENERAL INFORMATION
The questions in this questionnaire have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to average 50 hours per response,
including the time for reviewing instructions, searching existing data sources, gathering the data needed,
and completing and reviewing the questionnaire. Send comments regarding the accuracy of this burden
estimate or any other aspect of this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade Commission, 500 E Street, SW,
Washington, DC 20436.
I-1a.

OMB statistics.--Please report below the actual number of hours required and the cost to your
firm of preparing the reply to this questionnaire and completing the form.
Hours

Dollars

I-1b.

OMB feedback.--We are interested in any comments you may have for improving this
questionnaire in general or the clarity of specific questions. Please attach such comments to your
firm’s response or send them to the above address.

I-2.

Establishments covered.-- Provide the city, state, zip code, and brief description of each
establishment(s) covered by this questionnaire (see page 3 of the instruction booklet for reporting
guidelines). If your firm is publicly traded, please specify the stock exchange and trading symbol
in the footnote to the table.
Establishments
Covered1

City, State

Zip (5 digit)

Description

1
2
3
4
5
6
1

I-3.

Additional discussion on establishments consolidated in this questionnaire:

Petition support.--Does your firm support or oppose the petition?
Country
China

Support

Oppose

Take no position

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 3

PART I.--GENERAL INFORMATION--Continued
I-4.

Ownership.--Is your firm owned, in whole or in part, by any other firm?
No

Firm name

I-5.

Address

Extent of
ownership
(percent)

Related importers/exporters.--Does your firm have any related firms, either domestic or
foreign, that are engaged in importing calhypo from China into the United States or that are
engaged in exporting calhypo from China to the United States?
No
Firm name

I-6.

Yes--List the following information.

Yes--List the following information.
Address

Affiliation

Related producers.--Does your firm have any related firms, either domestic or foreign, that are
engaged in the production of calhypo?
No
Firm name

Yes--List the following information.
Address

Affiliation

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 4

PART II.--TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Fred Ruggles (202-205-3187,
fred.ruggles@usitc.gov). Supply all data requested on a calendar-year basis.
II-1.

Contact information.-- Please identify the responsible individual and the manner by which
Commission staff may contact that individual regarding the confidential information submitted in
part II.
Name
Title
Email
Telephone
Fax

II-2.

Changes in operations.--Please indicate whether your firm has experienced any of the following
changes in relation to the production of calhypo since January 1, 2011.
(check as many as appropriate)
plant openings ..............................

plant closings................................

relocations ....................................

expansions ....................................

acquisitions...................................

consolidations...............................

prolonged shutdowns or
production curtailments................
revised labor agreements ..............

other (e.g., technology) ................

(please describe)

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 5

PART II.--TRADE AND RELATED INFORMATION--Continued
II-3.

Same equipment, machinery, and workers for granules/powder or tablets &
product shifting.--Has your firm since 2011 produced, or does your firm anticipate producing in
the future, other products on the same equipment and machinery used in the production of
granular/powder or tableted calhypo and/or using the same production and related workers
employed to produce granular/powder or tableted calhypo?
No

Yes--Granular/powder (respond below)

Yes--Tablets (respond below)

If you checked “yes” (meaning that your firm is able to switch production between
granular/powder and other products or between tableted calhypo and other product using the
same equipment and labor), please identify the other products, the approximate time and cost
involved in switching, and the minimum relative price change required for your firm to switch
production to or from granular/powder or tableted calhypo.

II-4.

Production constraints and product shifting.--Please describe the constraint(s) that set the limit(s)
on your firm’s production capacity and its ability to shift production capacity between products.

II-5.

Type of operation.--Since January 1, 2011, which of the following activity is your firm involved
in the production of calhypo (check all that apply)?
Bulk granular/powder

II-6.

Tablets

Tolling.--Since January 1, 2011, has your firm been involved in a toll agreement (see definition
in the instruction booklet) regarding the production of calhypo?
No

Yes--Name firm(s):

If yes, check all that apply:
Your firm is a tollee (i.e., contracts out for the tableting production of calhypo).
Your firm is a toller (i.e., produces tableted calhypo under contract for other firm(s)).
IF YOUR FIRM IMPORTED GRANULAR/POWDER CALHYPO THAT IS TABLETED
UNDER A TOLLING ARRANGEMENT WITH A THIRD PARTY IN THE UNITED
STATES, REPORT YOUR SHIPMENTS AND SALES OF THE TOLL-PRODUCED
TABLETS IN YOUR U.S. IMPORTERS’ QUESTIONNAIRE. THE TOLL PRODUCER
SHOULD COMPLETE THOSE PARTS OF THIS U.S. PRODUCERS’
QUESTIONNAIRE ASSOCIATED WITH ITS TOLL PRODUCTION.

.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 6

PART II.--TRADE AND RELATED INFORMATION--Continued
II-7.

Foreign trade zone.--Does your firm produce calhypo in a foreign trade zone (FTZ)?
No

II-8.

Yes--Identify FTZ(s):

.

Importer.--Since January 1, 2011, has your firm imported calhypo?
No

Yes--COMPLETE AND RETURN A U.S. IMPORTERS’ QUESTIONNAIRE

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 7

PART II.--TRADE AND RELATED INFORMATION--Continued
II-9.

GRANULAR/POWDER CALHYPO.--Report your firm’s production capacity, production,
shipments, inventories, and employment related to the production of all granular/powder 
calhypo in its U.S. establishment(s) during the specified periods. (See definitions in the
instruction booklet.)
Quantity (in 1,000 pounds) and value (in $1,000)
Calendar years
Item

2011

2012

January-June
2013

2013

2014

Average production capacity1 (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Shipped for toll conversion:3
Quantity of merchandise shipped for tolling
Value of merchandise shipped for tolling
Value tolling fee contracted/paid
Export shipments:4
Quantity of export shipments
Value of export shipments
End-of-period inventories5 (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that your firm uses
a different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data
using that basis for each of the periods noted above:
3

Merchandise shipped for toll conversion is understood to mean any powder/granular calhypo your firm ships to any third
party (related or not) for conversion into tablets under a toll arrangement.
4
Identify your firm’s principal export markets:
.
5
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period
inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?
Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 8

PART II.--TRADE AND RELATED INFORMATION--Continued

II-10.

CHANNELS OF DISTRIBUTION FOR GRANULAR/POWDER CALHYPO.--Report your firm’s
total U.S. commercial shipments of powder/granular form of calhypo, by channel of distribution from its
U.S. establishment(s) during the specified periods.

Item

Quantity (in 1,000 pounds)
Calendar years
2011
2012

Retail market
Repackers/private label marketers/tableters
Distributors and dealers for private and
residential or commercial swimming pool
channels
Retailers/big-box stores
Service professionals (maintenance and
services to consumers and institutions)
Consumer and commercial swimming
pools, spas, etc.
Institutional and industrial applications
Manufacturers of bulk chemicals
Municipal water treatment
Total U.S. commercial shipments

0

January-June
2013
2014

2013

0

0

0

0

Reconciliation of Channels of Distribution.--Please ensure that the quantities reported for channels of
distribution (i.e., above) in each time period equal the quantities reported for commercial U.S. shipments from
question II-9 in each time period. The calculated fields test this reconciliation. If the calculated fields below
return values other than zero (i.e., “0”), the data in question II-9 or II-10 need to be revised prior to submission
to the Commission.
Reconciliation item
Should equal to zero (revise data II-9 or II10 if not zero)

Calendar years
2012

2011
0

0

January-June
2013
2014

2013
0

0

0

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 9

PART II.--TRADE AND RELATED INFORMATION--Continued

II-11.

TABLETED CALHYPO.--Report your firm’s production capacity, production, shipments, and
inventories related to the production of all tableted calhypo in its U.S. establishment(s).

Quantity (in 1,000 pounds) and value (in $1,000)
Calendar years
Item
2011
2012
2013
1
Average production capacity (quantity) (A)
Beginning-of-period inventories (quantity) (B)
Source of tablets:
Production of tablets:
From internally produced granular/powder calhypo (C)
From U.S.-produced granular/powder calhypo) (D)
From imported granular/powder calhypo (E)
From granular/powder calhypo received pursuant to a
toll arrangement (F)2
0
0
0
Subtotal: production of tablets
Finished product received from toll operations:
(quantity) (G)3
U.S. shipments of tableted calhypo:
Commercial shipments:
Quantity of commercial shipments (H)
Value of commercial shipments (I)
Internal consumption:
Quantity of internal consumption (J)
Value4 of internal consumption (K)
Transfers to related firms:
Quantity of transfers (L)
Value4 of transfers (M)
Toll production returned:5
Quantity shipped back to tollee (N)
Value fee(s) received for returned tablets (O)
Export shipments of tableted:6
Quantity of export shipments (P)
Value of export shipments (Q)
End-of-period inventories (quantity) (R)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
See footnotes on next page.

January-June
2013
2014

0

0

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 10

PART II.--TRADE AND RELATED INFORMATION--Continued
II-11.

TABLETED CALHYPO.--Continued

1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Report the data here for tablets your firm produced under a toll arrangement for which you are receiving a fee your
production services. To the degree to which the product is shipped back to the tollee within the period of production those
data should also be reported in line N of this data table.
3
Report the data here for tablets your firm received under a toll arrangement for which you paid a third party to convert
into tablets. Any sales or shipments of the tablets into the market should be reported under commercial shipments, internal
consumption, or transfers to related firms (e.g., not under "toll production returned).
4
Internal consumption and transfers to related firms must be valued at fair market value. In the event that your firm
uses a different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value
data using that basis for each of the periods noted above:
5
Toll production returned only applies to tollers who have converted powder/granular form calhypo to tablets for another
firm and have shipped those tablets back to the tollee who will actually end up selling them into the market.
6
Identify your firm’s principal export markets:
.

II-12.

CHANNELS OF DISTRIBUTION FOR TABLETED CALHYPO.--Report your firm’s total U.S.
commercial shipments of tableted calhypo, by channel of distribution from its U.S. establishment(s)
during the specified periods.
Quantity (in 1,000 pounds)
Calendar years
Item

2011

2012

January-June
2013

2013

2014

Retail market

Repackers/private label marketers/tableters
Distributors and dealers for private and
residential or commercial swimming pool
channels
Retailers/big-box stores
Service professionals (maintenance and
services to consumers and institutions)
Consumer and commercial swimming
pools, spas, etc.
Institutional and industrial applications

Manufacturers of bulk chemicals
Municipal water treatment
Total U.S. commercial shipments

0

0

0

0

0

Reconciliation of Channels of Distribution.--Please ensure that the quantities reported for channels of distribution (i.e.,
above) in each time period equal the quantities reported for commercial U.S. shipments from question II-11 in each time
period. The calculated fields test this reconciliation. If the calculated fields below return values other than zero (i.e., “0”),
the data in question II-11or II-12 need to be revised prior to submission to the Commission.
Calendar years
January-June
Reconciliation item
2011
2012
2013
2013
2014
Should equal to zero (revise data in II-11 or II12 if not zero)

0

0

0

0

0

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 11

PART II.--TRADE AND RELATED INFORMATION--Continued
II-13.

Related firms.--If your firm reported transfers to related firms in question II-9, please indicate
the nature of the relationship between your firm and the related firms (e.g., joint venture, wholly
owned subsidiary), whether the transfers were priced at market value or by a non-market formula,
whether your firm retained marketing rights to all transfers, and whether the related firms also
processed inputs from sources other than your firm.

II-14.

Purchases.--Other than direct imports, has your firm otherwise purchased calhypo since January
1, 2011? (See definitions in the instruction booklet.)
Yes--Report such purchases below for the specified periods.1

No

(Quantity in 1,000 pounds, value in $1,000)
Calendar years
Item

2011

2012

January-June
2013

2013

2014

PURCHASES FROM U.S. IMPORTERS2
OF CALHYPO FROM—
China:
Quantity
Value
All other countries:
Quantity
Value
PURCHASES FROM DOMESTIC
2
PRODUCERS:
Quantity
Value
PURCHASES FROM OTHER SOURCES:2
Quantity
Value
1
Please indicate your firm’s reasons for purchasing this product. If your firm’s reasons differ by source, please
elaborate.

2

Please list the name of the firm(s) from which your firm purchased this product. If your firm’s suppliers differ
by source, please identify the source for each listed supplier.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 12

PART II.--TRADE AND RELATED INFORMATION--Continued
II-15.

Differences associated with producing granular/powder versus tablets.--Please provide a
discussion of any differences involved in your firms’ U.S. production-related activities for
granular/powder versus tablet production, including the technical expertise needed for
granular/powder versus tablet production; the quantity and type of parts sourced in the United
States for granular/powder versus tablet production; and any other costs and activities involved in
granular/powder versus tablet production. Use additional pages as necessary.

II-16.

Other explanations.--If your firm would like to further explain a response to a question in Part II
that did not provide a narrative response box, please note the question number and the
explanation in the space provided below. Please also use this space to highlight any issues your
firm had in providing the data in this section, including but not limited to technical issues with the
MS Word questionnaire.

______

Business Proprietary
U.S. Producers’ Questionnaire - -- Calcium Hypochlorite from China (F)

Page 13

PART III.--FINANCIAL INFORMATION
Note: If you are answering this questionnaire because you are a toller that converts
powder/granular form calcium hypochlorite into tablet form for a third party under a tolling
agreement (and do not produce powder/granular form calcium hypochlorite) and you also
repackage calcium hypochlorite without converting between forms, limit your response to this
section of the questionnaire to information related to the tableting operation. Do not include
information related to the repackaging operation. In Question III-4, please explain how financial
information was allocated between the two operations.
Address questions on this part of the questionnaire to David Boyland (202-708-4725,
David.Boyland@usitc.gov).
III-1.

Contact information.--Please identify the responsible individual and the manner by which
Commission staff may contact that individual regarding the confidential information submitted in
part III.
Name
Title
Email
Telephone
Fax

III-2.

Accounting system.--Briefly describe your firm’s financial accounting system.
A.

When does your firm’s fiscal year end (month and day)?
If your firm’s fiscal year changed during the data-collection period, explain
below:

B.1.

Describe the lowest level of operations (e.g., plant, division, company-wide) for
which financial statements are prepared that include calhypo:

2.
3.

4.

Does your firm prepare profit/loss statements for the calhypo:
Yes
No
How often did your firm (or parent company) prepare financial statements
(including annual reports, 10Ks)? Please check relevant items below.
Audited,
unaudited,
annual reports,
10Ks,
10 Qs,
Monthly,
quarterly,
semi-annually,
annually
Accounting basis:
GAAP,
cash,
tax, or
other comprehensive
basis of accounting (specify)

Note: The Commission may request that your company submit copies of its financial statements,
including internal profit-and-loss statements for the division or product group that includes
calhypo, as well as those statements and worksheets used to compile data for your firm’s
questionnaire response.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 14

PART III.--FINANCIAL INFORMATION--Continued
III-3.

Cost accounting system.--Briefly describe your firm’s cost accounting system (e.g., standard
cost, job order cost, etc.).

______
III-4.

Allocation basis.--Briefly describe your firm’s allocation basis, if any, for COGS, SG&A, and
interest expense and other income and expenses. (See note at the beginning of this section
regarding distinction between tableting and repackaging operations).

III-5.

Other products.—Please list any other products your firm produced in the facilities in which
your firm produced calhypo, and provide the share of net sales accounted for by these other
products in your firm’s most recent fiscal year:
Products

calhypo

Share of sales

%
%
%
%
%

III-6.

Does your firm purchase inputs (raw materials, labor, energy, or any other services) used in the
production of calhypo from any related parties?
Yes--Continue to question III-7 below.

No--Continue to question III-9a below.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 15

PART III.--FINANCIAL INFORMATION--Continued
III-7.

Inputs from related parties.--In the space provided below, identify the inputs used in the
production of calhypo that your firm purchases from related parties. For “Share of total COGS”
please report this information by relevant input on the basis of your most recently completed
fiscal year. For “Input valuation” please describe the basis, as recorded in the company’s own
accounting system, of the purchase cost from the related party; e.g., the related party’s actual cost,
cost plus, negotiated transfer price to approximate fair market value.
Input

Related party

Share of total COGS

Input valuation

______

III-8.

Inputs from related parties at cost.-- All intercompany profit or loss on inputs purchased from
related parties, as well as intra-division profit or loss, should be eliminated from the costs
reported to the Commission in question III-9a; i.e., costs reported in question III-9a should only
reflect the related party’s cost and not include an associated profit or loss component. Reasonable
methods for determining and eliminating the associated profit on inputs purchased from related
parties are acceptable.
Has your firm complied with the Commission’s instructions regarding costs associated with
inputs purchased from related parties?
Yes--Please briefly describe how you eliminated intercompany/intra-division profit or (loss)
on inputs purchased/received from related firms/or intra-division units within the same company
to arrive at the actual costs incurred by the related firms/intra-division units.

No-- If an inter-company/intra-division profit or (loss) adjustment was applicable, please
explain why this adjustment was not made.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 16

PART III.--FINANCIAL INFORMATION--Continued
III-9a. Operations on calhypo.--Report the revenue and related cost information requested below on the
calhypo operations of your firm’s U.S. establishment(s).1 Do not report resales of products. Note
that internal consumption and transfers to related firms must be valued at fair market value and
purchases from related firms must be at cost.2 Provide data for your firm’s three most recently
completed fiscal years, and for the specified interim periods.
Quantity (in 1,000 pounds) and value (in $1,000)
Fiscal years ended-Item

2011

2012

January-June
2013

2013

2014

3

Net sales quantities:
Commercial sales (“CS”)
Internal consumption (“IC”)
Transfers to related firms (“Transfers”)
Total net sales quantities

0

0

0

0

0

0

0

0

0

0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0

0

0

0

0

Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other expenses and income:
Interest expense
All other expense items
All other income items
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please eliminate any profits or (losses) on inputs from related firms pursuant to question III-8.
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with CS, IC, and Transfers, as well as export shipments as reported in the relevant trade
section in part II.
2

3

Note -- The table above contains calculations that will appear when you have entered data in the MS
Word form fields.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 17

PART III.--FINANCIAL INFORMATION--Continued
III-9b. Financial data reconciliation.--The calculable line items from question III-9a. (i.e., total net
sales quantities and values, total COGS, gross profit (or loss), total SG&A, and net income (or
loss)) have been calculated from the data submitted in the other line items. Do the calculated
fields return the correct data according to your firm's financial records ignoring non-material
differences that may arise due to rounding?
Yes

No.--If the calculated fields do not show the correct data, please double check the
feeder data for data entry errors and revise.
Also, check signs accorded to the post operating income line items; the two
expense line items should report positive numbers (i.e., expenses are positive
and incomes or reversals are negative--instances of the latter should be rare
in those lines) while the income line item also in most instances should have
its value be a positive number (i.e., income is positive, expenses or reversals
are negative).
If after reviewing and potentially revising the feeder data your firm has
provided, the differences between your records and the calculated fields
persist please identify and discuss the differences in the space below.

III-10. Nonrecurring items (charges and gains) included in the subject product financial results.-For each annual and interim period for which financial results are reported in question III-9a,
please specify all material (significant) nonrecurring items (charges and gains) in the schedule
below, the specific table III-9a line item where the nonrecurring items are included, a brief
description of the relevant nonrecurring items, and the associated values (in $1,000), as reflected
in table III-9a; i.e., if an aggregate nonrecurring item has been allocated to table III-9a, only the
allocated value amount included in table III-9a should be reported in the schedule below. Note:
The Commission’s objective here is to gather information only on material (significant)
nonrecurring items which impacted the reported financial results of the subject product in table
III-9a.
Fiscal years ended-2011
Nonrecurring item: In this column please provide a
brief description of each nonrecurring item and indicate
the specific line item in table III-9a where the
nonrecurring item is classified.
1.

, classified

2.

, classified

3.

, classified

4.

, classified

5.

, classified

6.

, classified

7.

, classified

2012

January-June
2013

2013

2014

Nonrecurring item: In these columns please report the amount of the
relevant nonrecurring item reported in table III-9a.
Value ($1,000)

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 18

PART III.--FINANCIAL INFORMATION--Continued
III-11. Does your firm repackage as well as tablet calhypo products?
Yes

No

If yes, please explain the basis for identifying and attributing the information reported in III-12
(property, plant and equipment) and III-13a (capital expenditures and R&D expenses) to either
the repackaging operation or the tableting operation:

III-12. Property, plant and equipment.--Report the property, plant, and equipment (PP&E) associated
with the designated calhypo operations identified below. If your firm does not maintain in the
normal course of business some or all of the specific information necessary to calculate PP&E
relevant to the designated calhypo operations, please estimate this information based upon a
method (such as production, sales, or costs) that is consistent with your firm’s cost allocations in
table III-9a and/or III-13a. Provide data for your firm’s three most recently completed fiscal
years, and for the specified interim periods.
Note: Total property, plant, and equipment should reflect net assets after any accumulated
depreciation and allowances deducted. Total property, plant, and equipment should be allocated
to the subject products if the underlyting assets are also related to other products. In the space
below, please provide a brief explanation if there were any substantial changes in total property,
plant, and equipment value during the period; e.g., due to asset write-offs, revaluation, and major
purchases.

Value (in $1,000)
Fiscal years ended-Item

2011

2012

January-June
2013

2013

2014

Total PP&E – granular/powder operations
Total PP&E – tableting operations

III-13a. Capital expenditures and research and development expenses.--Report your firm’s capital
expenditures and general research and development (R&D) expenses for designated calhypo
operations. Provide data for your firm’s three most recently completed fiscal years, and for the
specified interim periods.
Value (in $1,000)
Fiscal years ended-Item
Capital expenditures – granular/powder operations
Capital expenditures – tableting operations
R&D expenses – granular/powder operations
R&D expenses – tableting operations

2011

2012

January-June
2013

2013

2014

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 19

PART III.--FINANCIAL INFORMATION--Continued
III-13b. Capital expenditures.--Please indicate the nature, focus, and significance of your firm’s capital
expenditures on the subject product.

III-14. Data consistency and reconciliation.--Please indicate whether your firm’s financial data for
questions III-9a, 12, and 13a are based on a calendar year or on your firm’s fiscal year:
Calendar year

Fiscal year

Specify fiscal year

Please note the quantities and values reported in question III-9a should reconcile with the relevant
trade data (including export shipments) reported in part II of this questionnaire; i.e., as long as
they are reported on the same calendar year basis.
Do these data in question III-9a reconcile with the relevant trade data reported in part II of this
questionnaire?
Yes

No

If no, please explain.

III-15a. Effects of imports.--Since January 1, 2011, has your firm experienced any actual negative effects
on its return on investment or its growth, investment, ability to raise capital, existing development
and production efforts (including efforts to develop a derivative or more advanced version of the
product), or the scale of capital investments as a result of imports of calhypo from China?
No

Yes--My firm has experienced actual negative effects as follows:
Cancellation, postponement, or rejection of expansion projects
Denial or rejection of investment proposal
Reduction in the size of capital investments
Rejection of bank loans
Lowering of credit rating
Problem related to the issue of stocks or bonds
Other (specify):

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 20

PART III.--FINANCIAL INFORMATION--Continued
III-15b. Anticipated effects of imports.--Does your firm anticipate any negative effects due to imports of
calhypo from China?
No

Yes

If yes, my firm anticipates negative effects as follows:

III-16. Other explanations:--If your firm would like to further explain a response to a question in Part
III that did not provide a narrative box, please note the question number and the explanation in
the space provided below. Please also use this space to highlight any issues your firm had in
providing the data in this section, including but not limited to technical issues with the MS Word
questionnaire.

______

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 21

PART IV.--PRICING AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from James Fetzer (202-708-5403,
James.Fetzer@usitc.gov)
IV-1.

Contact information.--Please identify the individual that Commission staff may contact
regarding the confidential information submitted in part IV.
Name
Title
Email
Telephone
Fax

PRICE DATA
IV-2. This question requests quarterly quantity and value data, f.o.b. your firm’s U.S. point of
shipment, for your firm’s commercial shipments to unrelated U.S. customers since January 1,
2011 of the following products produced by your firm.
Note that some or all of the products that you produce may not match these specifications. If that
is the case, do not report data for these products unless the product is competitive with one of
these products. However, please respond to the other questions in Part IV with respect to all your
sales or use of calhypo.
Product 1. --

Calcium Hypochlorite, 65%-73% available chlorine, granular, 100 lbs., however
packaged, sold into the repacker/private label/tableter channel.

Product 2.--

Calcium Hypochlorite, 65%-73% available chlorine, granular, 100 lbs., however
packaged, sold directly to distributors or dealers that serve the private residential
or commercial swimming pool channels.

Product 3. --

Calcium Hypochlorite, 65%-73% available chlorine, granular, 100 lbs., however
packaged, sold to retailers/big box stores.

Product 4. --

Calcium Hypochlorite, 65%-73% available chlorine, granular, 25 lbs., however
packaged, sold into the repacker/private label/tableter channel.

Product 5.--

Calcium Hypochlorite, 65%-73% available chlorine, granular, 25 lbs., however
packaged, sold directly to distributors or dealers that serve the private residential
or commercial swimming pool channels.

Product 6. --

Calcium Hypochlorite, 65%-73% available chlorine, granular, 25 lbs., however
packaged, sold to retailers/big box stores.

Please note that total dollar values should be f.o.b., U.S. point of shipment and should not include
U.S.-inland transportation costs. Total dollar values should reflect the final net amount paid to
your firm (i.e., should be net of all deductions for discounts or rebates). See instruction booklet.
During January 2011-June 2014, did your firm produce and sell to unrelated U.S. customers any of the
above listed products (or any products that were competitive with these products)?
Yes.--Please complete the following pricing data table as appropriate.
No.--Skip to question IV-3.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 22

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-2.

Pricing data.--Report below the quarterly price data1 for pricing products2 produced and sold by
your firm.

Report data in actual pounds and actual dollars (not 1,000s).
(Quantity in pounds, value in dollars)
Product 1
Product 2
Quantity
Value
Quantity
Value

Product 3
Period of shipment
Quantity
Value
2011:
January-March
April-June
July-September
October-December
2012:
January-March
April-June
July-September
October-December
2013:
January-March
April-June
July-September
October-December
2014:
January-March
April-June
1
Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of
returned goods), f.o.b. your firm’s U.S. point of shipment.
2
Pricing product definitions are provided on the first page of Part IV.
Note.--If your firm’s product does not exactly meet the product specifications but is competitive with the specified
product, provide a description of your firm’s product. Also, please explain any anomalies in your firm’s reported
pricing data.
Product 1:
Product 2:
Product 3:

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 23

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-2.

Pricing data (continued).--Report below the quarterly price data1 for pricing products2 produced
and sold by your firm.
Report data in actual pounds and actual dollars (not 1,000s).
(Quantity in pounds, value in dollars)
Product 4
Product 5
Quantity
Value
Quantity
Value

Product 6
Period of shipment
Quantity
Value
2011:
January-March
April-June
July-September
October-December
2012:
January-March
April-June
July-September
October-December
2013:
January-March
April-June
July-September
October-December
2014:
January-March
April-June
1
Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of
returned goods), f.o.b. your firm’s U.S. point of shipment.
2
Pricing product definitions are provided on the first page of Part IV.
Note.--If your firm’s product does not exactly meet the product specifications but is competitive with the specified
product, provide a description of your firm’s product. Also, please explain any anomalies in your firm’s reported
pricing data.
Product 4:
Product 5:
Product 6:

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 24

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-3.

Price setting.-- How does your firm determine the prices that it charges for sales of calhypo
(check all that apply)? If your firm issues price lists, please submit sample pages of a recent list.
Transaction
by
transaction

IV-4.

Contracts

Other

If other, describe

Discount policy.-- Please indicate and describe your firm’s discount policies (check all that
apply).

Quantity
discounts

IV-5.

Set
price
lists

Annual
total
volume
discounts

No
discount
policy

Other

Describe

Customer rewards programs.-(a)

Does your firm offer customer rewards programs for products including calhypo?
No -- skip to question IV-6.
Yes -- please respond to part (b)

(b)

Identify the share of your firm’s 2013 sales of calhypo that were affected by a customer
rewards program and estimate the total cost of the rewards program.
Share of your firm’s 2013 sales of calhypo that were part of
a customer rewards program
Estimate the total cost of customer rewards programs that
could have affected sales of calhypo

IV-6.

%

Pricing terms for calhypo.-(a)

What are your firm’s typical sales terms for its U.S.-produced calhypo?
Net 30
days

(b)

Net 60
days

2/10 net
30 days

Other

Other (specify)

On what basis are your firm’s prices of domestic calhypo usually quoted (check one)?
Delivered

F.o.b.

If f.o.b., specify point

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 25

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-7.

Contract versus spot.--Approximately what share of your firm’s sales of its U.S.-produced
calhypo in 2013 was on a (1) long-term contract basis, (2) short-term contract basis, and (3) spot
sales basis?
Share of
2013 sales

Type of sale
Long-term contracts (multiple deliveries for more
than 12 months)

%

Short-term contracts (multiple deliveries up to and
including 12 months)

%

Spot sales (for a single delivery)

%

Total (should sum to 100%)

IV-8.

0.0

%

Contract provisions.— Please fill out the table with respect to provisions of your firm’s typical
sales contracts for calhypo (or check “not applicable” if your firm does not sell on a long-term
and/or short-term contract basis).

Typical sales contract
provisions

Item

Average contract duration

Number of days

Price renegotiation (during the
contract period)

Yes

Short-term contracts

Long-term contracts

(multiple deliveries up to
and including 12 months)

(multiple deliveries for more
than 12 months)

No
Quantity

Fixed quantity and/or price

Price
Both

Meet or release provision

Yes
No

Not applicable

IV-9.

Lead times.--What is your firm’s share of sales both from inventory and produced to order and
what is the typical lead time between a customer’s order and the date of delivery for your firm’s
sales of its U.S.-produced calhypo?
Source

Share of
2013 sales

From inventory

%

Produced to order

%

Total (should sum to 100%)

0.0

%

Lead time (days)

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 26

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-10. Shipping information.-(a)

What is the approximate percentage of the total delivered cost of calhypo that is
accounted for by U.S. inland transportation costs?
%

(b)

Who generally arranges the transportation to your firm’s customers’ locations?
Your firm
Purchaser (check one)

(c)

Indicate the approximate percentage of your firm’s sales of calhypo that are delivered the
following distances from its production facility.
Distance from production facility

Share

Within 100 miles

%

101 to 1,000 miles

%

Over 1,000 miles

%

Total (should sum to 100%)

0.0

%

IV-11. Geographical shipments.-- In which U.S. geographic market area(s) has your firm sold its U.S.produced calhypo since January 1, 2011 (check all that apply)?
Geographic area

√ if applicable

Northeast.–CT, ME, MA, NH, NJ, NY, PA, RI, and VT.
Midwest.–IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI.
Southeast.–AL, DE, DC, FL, GA, KY, MD, MS, NC, SC, TN, VA, and WV.
Central Southwest.–AR, LA, OK, and TX.
Mountains.–AZ, CO, ID, MT, NV, NM, UT, and WY.
Pacific Coast.–CA, OR, and WA.
Other.–All other markets in the United States not previously listed, including AK, HI,
PR, and VI, among others.

IV-12. End uses.--List the end uses of the calhypo that your firm manufactures. For each end-use
product, what percentage of the total cost is accounted for by calhypo and other inputs?
Share of total cost of end use product
accounted for by
End use product

Calhypo

Other inputs

Total

%

%

0.0 %

%

%

0.0 %

%

%

0.0 %

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 27

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-13. Substitutes.-- Can other products be substituted for calhypo?
No

Yes--Please fill out the table.

End use in which this
substitute is used

Substitute

Have changes in the prices of this substitute
affected the price for calhypo?
No Yes

Explanation

1.
2.
3.

IV-14. Chlorine content.-(a)

Can calhypo products that differ only in their available chlorine levels serve as
commercial substitutes with little or no reprocessing by the seller?
No

(b)

Yes

Explain

Report the share of your firm’s U.S. commerical shipments of calhypo by available
chlorine content.

Chlorine content
47 – 56 percent
65 – 68 percent
70 percent and above
Other:
Total (should sum to 100%)

Share of 2013
U.S. commercial
shipments
%
%
%
%
0.0 %

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 28

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-15. Demand trends.-- Indicate how demand within the United States and outside of the United States
(if known) for calhypo has changed since January 1, 2011. Explain any trends and describe the
principal factors that have affected these changes in demand.

Market

Fluctuate
Overall
No
Overall
with no
increase change decrease clear trend

Explanation and factors

Within
the United
States
Outside
the United
States

IV-16. Product changes.--Have there been any significant changes in the product range, product mix, or
marketing of calhypo since January 1, 2011?
No

Yes

If yes, please describe and quantify if possible.

IV-17. Business cycles.-(a) Is the calhypo market subject to business cycles (other than general economy-wide conditions)
and/or other conditions of competition distinctive to calhypo?
Check all that apply.
No

Please describe.
Skip to question IV-18.

Yes-Business cycles (e.g.
seasonal business)
Yes-Other distinctive
conditions of competition

(b) If yes, have there been any changes in the business cycles or conditions of competition for
calhypo since January 1, 2011?
No

Yes

If yes, please describe.

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 29

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-18. Supply constraints.--Has your firm refused, declined, or been unable to supply calhypo since
January 1, 2011 (examples include placing customers on allocation or “controlled order entry,”
declining to accept new customers or renew existing customers, delivering less than the quantity
promised, been unable to meet timely shipment commitments, etc.)?
No

Yes

If yes, please describe.

IV-19. Raw materials.--How have calhypo raw materials prices changed since January 1, 2011?
Fluctuate
with no Explain, noting how raw material price changes
Overall
No
Overall
clear
have affected your firm’s selling prices for
increase change decrease
trend
calhypo.

IV-20. Interchangeability.--Is calhypo produced in the United States and in other countries
interchangeable (i.e., can they physically be used in the same applications)?
Please indicate A, F, S, N, or 0 in the table below:
A = the products from a specified country-pair are always interchangeable
F = the products are frequently interchangeable
S = the products are sometimes interchangeable
N = the products are never interchangeable
0 = no familiarity with products from a specified country-pair

Country-pair

China

Other countries

United States
China

For any country-pair producing calhypo that is sometimes or never interchangeable, please
explain the factors that limit or preclude interchangeable use:

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 30

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-21. Factors other than price.--Are differences other than price (i.e., quality, availability,
transportation network, product range, technical support, etc.) between calhypo produced in the
United States and in other countries a significant factor in your firm’s sales of the products?
Please indicate A, F, S, N, or 0 in the table below:
A = such differences are always significant
F = such differences are frequently significant
S = such differences are sometimes significant
N = such differences are never significant
0 = no familiarity with products from a specified country-pair
Country-pair

China

Other countries

United States
China

For any country-pair for which factors other than price always or frequently are a significant
factor in your firm’s sales of calhypo, identify the country-pair and report the advantages or
disadvantages imparted by such factors:

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 31

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-22. Customer Identification--Please identify the names and contact information for your firm’s
10 largest U.S. customers for calhypo since January 1, 2011. Indicate the share of the quantity of
your firm’s total shipments of calhypo that each of these customers accounted for in 2013.
Customer’s name
1
2
3
4
5
6
7
8
9
10

City and state
,
City

State

,
City

State

,
City

State

,
City

State

,
City

State

,
City

State

,
City

State

,
City

State

,
City

State

,
City

State

Share of 2013
sales (%)

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 32

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-23. Competition From Imports--Lost Revenue.-Since January 1, 2011: To avoid losing sales to competitors selling calhypo from China, did your
firm:
No

Yes

Reduce prices
Roll back announced price increases
Please DO NOT RE-SUBMIT allegations provided in the preliminary phase of this
proceeding.
If you indicated “yes” above, please furnish the following information for each affected
transaction. If possible, provide documentation (e.g., copies of invoices, sales reports, or letters
from customers). Please note that the Commission may contact the firms named to verify the
allegations reported.
Customer name, contact person, phone and fax numbers
Specific product(s) involved
Date of your firm’s initial price quotation
Quantity involved
Your firm’s initial rejected price quotation (total delivered value)
Your firm’s accepted price quotation (total delivered value)
The country of origin of the competing imported product
The competing price quotation of the imported product (total delivered value)
Customer name,
contact person,
email, phone and
fax numbers

Firm
Contact

Email

Phone

Fax

Firm
Contact

Email

Phone

Fax

Firm
Contact

Email

Phone

Fax

Firm
Contact

Email

Phone

Fax

Product

Country
of origin

Date of
quote

Quantity
(pounds)

Initial
rejected U.S.
price (total
value-dollars)

Accepted
U.S. price
(total value-dollars)

Competing
import price
(total
value—
dollars)

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 33

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-24. Competition From Imports--Lost Sales.—
Since January 1, 2011: Did your firm lose sales of calhypo to imports of these products from
China?
No
Yes
Please DO NOT RE-SUBMIT allegations provided in the preliminary phase of this
proceeding.
If you indicated “yes” above, please furnish the following information for each affected
transaction. If possible, provide documentation (e.g., copies of invoices, sales reports, or letters
from customers). Please note that the Commission may contact the firms named to verify the
allegations reported.
Customer name, contact person, phone and fax numbers
Specific product(s) involved
Date of your firm’s price quotation
Quantity involved
Your firm’s rejected price quotation (total delivered value)
The country of origin of the competing imported product
The accepted price quotation of the imported product (total delivered value)
Customer name,
contact person,
email, phone and
fax numbers

Firm
Contact

Email

Phone

Fax

Firm
Contact

Email

Phone

Fax

Firm
Contact

Email

Phone

Fax

Firm
Contact

Email

Phone

Fax

Product

Country
of
origin

Date of
quote

Quantity
(pounds)

Rejected
U.S. price
(total
value-dollars)

Competing
import price
(total
value—
dollars)

Business Proprietary
U.S. Producers’ Questionnaire -- Calcium Hypochlorite from China (F)

Page 34

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-25. Other explanations.--If your firm would like to further explain a response to a question in Part
IV that did not provide a narrative response box, please note the question number and the
explanation in the space provided below. Please also use this space to highlight any issues your
firm had in providing the data in this section, including but not limited to technical issues with the
MS Word questionnaire.